We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

News   May 17, 2018 | Original story from Sartorius

 
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

ambr® 250 bioreactor system

 
 
 

RELATED ARTICLES

A Research Partnership to Find Treatments for Neurological Disorders

News

BioMotiv and Cure Network Dolby Acceleration Partners launch a collaboration to find better treatments for brain disorders.

READ MORE

New 3D-printed Device Could Help Treat Spinal Cord Injuries

News

Researchers hope their neuronal stem cell scaffold could be surgically implanted to help spinal cord injury patients.

READ MORE

Retinoic Acid may Improve Immune Response Against Melanoma

News

Scientists have found a promising strategy to remove one of melanoma’s most powerful defenses, leading to more immune system activity directed at melanoma.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE